Search

Your search keyword '"Pizard, Anne"' showing total 173 results

Search Constraints

Start Over You searched for: Author "Pizard, Anne" Remove constraint Author: "Pizard, Anne"
173 results on '"Pizard, Anne"'

Search Results

1. The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial

3. Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF

5. Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

6. Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure: The HOMAGE Study

10. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial

11. The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial

13. Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis

14. Palmitoylation of the human bradykinin B(sub)2 receptor influences ligand efficacy

17. Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials

20. A data science approach for exploring differential expression profiles of genes in transcriptomic studies-Application to the understanding of ageing in obese and lean rats in the FIGHT-HF project

21. Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case–control analyses.

22. Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure

25. Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France

27. Selective Involvement of Serum Response Factor in Pressure-Induced Myogenic Tone in Resistance Arteries

28. Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis

30. Risk for Incident Heart Failure: A Subject‐Level Meta‐Analysis From the Heart “OMics” in AGEing (HOMAGE) Study

33. Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure.

34. 0356 : Disseminated arterial calcification and enhanced myogenic response are associated with Abcc6 deficiency in a mouse model of pseudoxanthoma elasticum

35. 0298: The early mineralocorticoid receptor antagonism mitigates the metabolic syndrome symptoms and transition to heart failure in the SHHF rat model

36. Smooth Muscle Cell Mineralocorticoid Receptors Are Mandatory for Aldosterone–Salt to Induce Vascular Stiffness

38. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats

39. Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function

40. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease

41. Corrigendum to “Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis” [Dev. Biol. 297 (2006) 566–586]

44. Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss

47. Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy

50. Simultaneous Characterization of Metabolic, Cardiac, Vascular and Renal Phenotypes of Lean and Obese SHHF Rats.

Catalog

Books, media, physical & digital resources